SAN DIEGO, July 25 (Bernama-BUSINESS WIRE) — Fast Company Magazine has awarded pioneering life sciences company Xenco Medical with its prestigious 2024 Innovation by Design Award for its groundbreaking TrabeculeX Continuum, the first convergent technology bridging regenerative medicine and digital health. Unveiled by Xenco Medical at CES 2024, the heralded platform’s unification of biomaterial implantation and remote therapeutic monitoring has signified an important advancement in the extent to which surgeons can maintain a continuous link with patients from the intraoperative phase throughout the entire course of recovery. The distinguished award marks the second time in two consecutive years that Xenco Medical has been recognized by Fast Company Magazine for its breakthrough innovations. Last year, Xenco Medical was named one of the World’s Most Innovative Companies by the esteemed publication.
“We are immensely honored to receive Fast Company’s 2024 Innovation by Design Award for the TrabeculeX Continuum and deeply grateful for their recognition of our technology’s capacity to upend the siloed nature of surgical care. Devoted to the longitudinal recovery of our patients, we look forward to the continued impact of the TrabeculeX Continuum as a seamless link from implantation to full mobility,” said Xenco Medical Founder and CEO Jason Haider.